Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoît Rousseau

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Bulletin Du Cancer|August 29, 2018
[Genealogy of lymph node and visceral metastases in colorectal cancer: "sisters" or "cousins"?]Julien Vibert, Benoît Rousseau
Perception & Psychophysics|September 25, 2002
The multiple dual-pair methodBenoît Rousseau, Daniel M Ennis
Perception & Psychophysics|July 31, 2004
Are three-sample tasks less sensitive than two-sample tasks? Memory effects in the testing of taste discriminationSamantha Lau, Michael O'Mahony, Benoît Rousseau
JAMA Oncology|March 6, 2020
Evaluation of POLE/POLD1 Variants as Potential Biomarkers for Immune Checkpoint Inhibitor Treatment OutcomesBenoît Rousseau, Joana Vidal, Luis A Diaz
Cancers|January 2, 2020
Immune Therapy for Liver CancersMarc Hilmi, Angélique Vienot, Benoît Rousseau, et al.
Bulletin Du Cancer|February 29, 2016
[Medical management of cholangiocarcinomas in 2015]Grégoire Marret, Cindy Neuzillet, Benoît Rousseau, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|March 2, 2016
KRAS oncogene in lung cancer: focus on molecularly driven clinical trialsEmmanuelle Kempf, Benoît Rousseau, Benjamin Besse, et al.
Experimental Eye Research|July 23, 2003
Involvement of fibroblast growth factors in choroidal angiogenesis and retinal vascularizationBenoît Rousseau, Frédéric Larrieu-Lahargue, Andréas Bikfalvi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2015
Negative Trials for Foreseeable Safety Reasons in Advanced Hepatocellular Carcinoma: How Long Are We Going to Take Lightly Pharmacokinetics of Tyrosine Kinase Inhibitors?Mohamed Bouattour, Benoît Rousseau, Johanna Wassermann, et al.
Bulletin Du Cancer|August 1, 2017
[Therapeutic drug monitoring - 4th edition of the congress of pharmacology of anticancer drugs]Marie Allard, Benoît Rousseau, Evelina Cardoso, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Bulletin Du Cancer|August 29, 2018
[Genealogy of lymph node and visceral metastases in colorectal cancer: "sisters" or "cousins"?]Julien Vibert, Benoît Rousseau
Perception & Psychophysics|September 25, 2002
The multiple dual-pair methodBenoît Rousseau, Daniel M Ennis
Perception & Psychophysics|July 31, 2004
Are three-sample tasks less sensitive than two-sample tasks? Memory effects in the testing of taste discriminationSamantha Lau, Michael O'Mahony, Benoît Rousseau
JAMA Oncology|March 6, 2020
Evaluation of POLE/POLD1 Variants as Potential Biomarkers for Immune Checkpoint Inhibitor Treatment OutcomesBenoît Rousseau, Joana Vidal, Luis A Diaz
Cancers|January 2, 2020
Immune Therapy for Liver CancersMarc Hilmi, Angélique Vienot, Benoît Rousseau, et al.
Bulletin Du Cancer|February 29, 2016
[Medical management of cholangiocarcinomas in 2015]Grégoire Marret, Cindy Neuzillet, Benoît Rousseau, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|March 2, 2016
KRAS oncogene in lung cancer: focus on molecularly driven clinical trialsEmmanuelle Kempf, Benoît Rousseau, Benjamin Besse, et al.
Experimental Eye Research|July 23, 2003
Involvement of fibroblast growth factors in choroidal angiogenesis and retinal vascularizationBenoît Rousseau, Frédéric Larrieu-Lahargue, Andréas Bikfalvi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2015
Negative Trials for Foreseeable Safety Reasons in Advanced Hepatocellular Carcinoma: How Long Are We Going to Take Lightly Pharmacokinetics of Tyrosine Kinase Inhibitors?Mohamed Bouattour, Benoît Rousseau, Johanna Wassermann, et al.
Bulletin Du Cancer|August 1, 2017
[Therapeutic drug monitoring - 4th edition of the congress of pharmacology of anticancer drugs]Marie Allard, Benoît Rousseau, Evelina Cardoso, et al.
Pageof 6